Petitioner Defends Inter Partes Review Request In Reply To Board
ALEXANDRIA, Va. — A medical technology company in a Feb. 11 brief maintains that the Patent Trial and Appeal Board properly instituted inter partes review (IPR) of a patent describing the...To view the full article, register now.
Already a subscriber? Click here to view full article